Generate a structured brief β facts, issues, held, reasoning, and significance β for this case in seconds. Or browse the verbatim judgment via the source links below.
PK Investments Limited seeks summary judgment of a claim made against Mr Sabaratnam issued on 9 January 2023. The claim form and particulars of claim plead that Mr Sabaratnam acted in breach of his duties owed to a company known as Finno Medical Limited (the βCompanyβ). The breach, it is claimed, caused loss to its creditors as a whole.
The application for summary judgment, dated 10 October 2023, is resisted by Mr Sabaratnam on the ground that there are significant factual disputes that necessitate a full trial. His position is that his defence, dated 23 February 2023, discloses a factual basis that has a real prospect of success.
Mr Sabaratnam was appointed director of the Company on 19 October 2015. The Company imported medicines into the UK from the EU. It repackaged, relabelled and sold the medicines to UK wholesalers for a profit.
A compulsory winding up order was made on 12 December 2018. The estimated deficiencies, according to the Official Receiversβ report of 23 January 2019, is Β£2,645,486.61.
PK Investments is a Maltese company and legal assignee of the claims vested in the Company. The assignment in favour of PK Investments is made by deed dated 1 June 2021. It was negotiated and executed by the liquidator of the Company acting as its agent. By clause 2.1 of the deed the Company as assignor:
Auto-extracted from The National Archives. Full structured brief in progress β the source links below give you the verbatim judgment in the meantime.
Put your case reading into practice. The free readiness diagnostic covers SQE1 subjects and highlights where to revise next. No account needed.
Try the free SQE1 diagnosticMultiple official and mirror sources β pick whichever loads cleanly on your network.
[2026] UKSC 6
Common Room
0 comments Β· About the Common Room β
No comments yet β start the discussion.
Voted-best comments help future students and feed Caselaw's AI study tools.